Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: June 2021

MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Announces Participation at Life Sciences Investor Forum

Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, will be participating in the upcoming Life Sciences Investor Forum, scheduled for June 24, 2021. During the presentation, Cybin’s CEO Doug Drysdale will provide an overview of … Continue reading

Posted in Cybin Inc. CLXPF | Leave a comment

MissionIRNewsBreaks – TAAT(TM) Global Alternatives Inc. (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) Recaps Milestones at First Anniversary of Public Trading

TAAT(TM) (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP2) today provided a summary of several notable accomplishments it has achieved since first listing on the Canadian Securities Exchange (“CSE”) one year ago. The company’s many milestones include the multinational commercialization of TAAT(TM) … Continue reading

Posted in TAAT Lifestyle & Wellness Ltd. TOBAF | Leave a comment

MissionIRNewsBreaks – Pressure BioSciences Inc. (PBIO) to Present, Share Highlights at Emerging Growth Conference

Pressure BioSciences (OTCQB: PBIO) has announced its CEO will be participating in the upcoming Emerging Growth Conference. PBIO is a leader in the development and sale of innovative, broadly enabling, pressure-based instruments, consumables, and services to the worldwide life sciences, … Continue reading

Posted in Pressure BioSciences Inc. PBIO | Leave a comment

MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Committed to Driving Novel Treatments Forward with Key Focus on Berubicin

CNS Pharmaceuticals’ (NASDAQ: CNSP) lead drug candidate, Berubicin, is a novel anthracycline, the first of which to appear capable of crossing the blood-brain barrier based on limited clinical data. The company is currently developing Berubicin in the treatment of several … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

MissionIRNewsBreaks – XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Advancing Rotigotine Development Program for Parkinson’s

XPhyto Therapeutics (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience technology accelerator, recently announced its drug formulation and development, conducted primarily by its wholly owned German subsidiary, Vektor Pharma TF GmbH, are on schedule and continue to expand in scope. … Continue reading

Posted in XPhyto Therapeutics Corp. XPHYF | Leave a comment

Nextech AR Solutions Corp. (CSE: NTAR) (OTCQB: NEXCF) Driving AR Adoption, Digital Transformation

According to CEO Evan Gappelberg, Nextech is the only diversified small-cap company participating in the rapidly growing digital transformation The company is ideally positioned to capitalize on the rapid market adoption environment accompanying the ongoing evolution of AR-led technology A … Continue reading

Posted in Nextech AR Solutions Corp. NEXCF | Leave a comment

MissionIRNewsBreaks – Splash Beverage Group Inc.’s (SBEV) Pulpoloco Sales up 75%, Demonstrating Value of Sustainability Advantage

Splash Beverage Group (OTCQB: SBEV), a portfolio company of leading beverage brands, today announced enhancing its commitment to developing market share for sustainably focused, innovative and socially conscious brands. According to the update, reports published by Nielsen highlight that 66% … Continue reading

Posted in Splash Beverage Group Inc. SBEV | Leave a comment

The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Sits in Top Independent Spot in Alkaline Water Space

WTER 2020 FY revenues make company largest alkaline water company in the U.S. In addition, the brand is one of the top-10 largest enhanced water brands in the country Research shows that Alkaline88 has the greatest brand loyalty among alkaline … Continue reading

Posted in The Alkaline Water Company Inc. WTER | Leave a comment

Predictive Oncology Inc.’s (NASDAQ: POAI) TumorGenesis Partners with Cellevate for New Approach to Ovarian Cancer

Collaboration will use TumorGenesis’ expertise in cancer cell culture growth media in combination with Cellevate’s specialty in emerging field of nanofiber matrixes.  Cutting-edge technology can help avoid mistakes in $2.6 billion process of bringing new drugs through FDA process. Coupling … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment

MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) CEO Discusses Following Passion in Optimal Self Conversations Interview

PlantX Life’s (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) CEO Julia Frank recently appeared on Optimal Self Conversations, an inspirational forum hosted by Jeremy Herider, a three-sport professional athlete and productivity coach. The podcast features interviews with inspirational trend setters who, … Continue reading

Posted in PlantX Life Inc. PLTXF | Leave a comment